Scientific letter
Pericardial effusion associated with mesalamine treatment in a patient with ulcerative colitis
Derrame pericárdico asociado al tratamiento con mesalazina en un paciente con colitis ulcerosa
Alberto Ezquerraa,
, Elena Resinaa, Álvaro Montesb, Tomás Álvarez-Maléa, Javier P. Gisberta
Corresponding author
a Servicio de Aparato Digestivo, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain
b Servicio de Cardiología, Hospital Universitario de La Princesa, Madrid, Spain
Read
328
Timeswas read the article
63
Total PDF
265
Total HTML
Share statistics
array:24 [ "pii" => "S2444382421002121" "issn" => "24443824" "doi" => "10.1016/j.gastre.2020.10.008" "estado" => "S300" "fechaPublicacion" => "2021-12-01" "aid" => "1672" "copyright" => "Elsevier España, S.L.U.. All rights reserved" "copyrightAnyo" => "2020" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Gastroenterol Hepatol. 2021;44:721-3" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0210570520303770" "issn" => "02105705" "doi" => "10.1016/j.gastrohep.2020.10.003" "estado" => "S300" "fechaPublicacion" => "2021-12-01" "aid" => "1672" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Gastroenterol Hepatol. 2021;44:721-3" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta científica</span>" "titulo" => "Derrame pericárdico asociado al tratamiento con mesalazina en un paciente con colitis ulcerosa" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "721" "paginaFinal" => "723" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Pericardial effusion associated with mesalamine treatment in a patient with ulcerative colitis" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1457 "Ancho" => 2917 "Tamanyo" => 268152 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A) Secuencia cine en cuatro cámaras que muestra pericardio de grosor normal con derrame pericárdico leve-moderado. B) Secuencia de realce tardío que muestra ausencia de realce en hojas pericárdicas, compatible con ausencia de inflamación activa.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Alberto Ezquerra, Elena Resina, Álvaro Montes, Tomás Álvarez-Malé, Javier P. Gisbert" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Alberto" "apellidos" => "Ezquerra" ] 1 => array:2 [ "nombre" => "Elena" "apellidos" => "Resina" ] 2 => array:2 [ "nombre" => "Álvaro" "apellidos" => "Montes" ] 3 => array:2 [ "nombre" => "Tomás" "apellidos" => "Álvarez-Malé" ] 4 => array:2 [ "nombre" => "Javier" "apellidos" => "P. Gisbert" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2444382421002121" "doi" => "10.1016/j.gastre.2020.10.008" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2444382421002121?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210570520303770?idApp=UINPBA00004N" "url" => "/02105705/0000004400000010/v1_202111240558/S0210570520303770/v1_202111240558/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S244438242100211X" "issn" => "24443824" "doi" => "10.1016/j.gastre.2020.10.007" "estado" => "S300" "fechaPublicacion" => "2021-12-01" "aid" => "1671" "copyright" => "Elsevier España, S.L.U." "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Gastroenterol Hepatol. 2021;44:724-5" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Image of the month</span>" "titulo" => "Endoscopic image simulating a rectal neoplasm in a case of ischemic colitis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "724" "paginaFinal" => "725" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Imagen endoscópica simulando una neoplasia de recto en un caso de colitis isquémica" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 623 "Ancho" => 750 "Tamanyo" => 57728 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0010" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Second colonoscopy image: expansive, bumpy, friable and stenosing lesion in the upper rectum.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Antonio Garrido-Serrano, María Belvis-Jiménez, Belén Maldonado-Pérez, Rafael Romero-Castro" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Antonio" "apellidos" => "Garrido-Serrano" ] 1 => array:2 [ "nombre" => "María" "apellidos" => "Belvis-Jiménez" ] 2 => array:2 [ "nombre" => "Belén" "apellidos" => "Maldonado-Pérez" ] 3 => array:2 [ "nombre" => "Rafael" "apellidos" => "Romero-Castro" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0210570520303769" "doi" => "10.1016/j.gastrohep.2020.10.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210570520303769?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S244438242100211X?idApp=UINPBA00004N" "url" => "/24443824/0000004400000010/v1_202112030713/S244438242100211X/v1_202112030713/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2444382421002212" "issn" => "24443824" "doi" => "10.1016/j.gastre.2020.09.010" "estado" => "S300" "fechaPublicacion" => "2021-12-01" "aid" => "1691" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Gastroenterol Hepatol. 2021;44:720-1" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific letter</span>" "titulo" => "Recurrent <span class="elsevierStyleItalic">Clostridium difficile</span> infection treated with bezlotoxumab in a liver transplant patient" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "720" "paginaFinal" => "721" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Infección recurrente por <span class="elsevierStyleItalic">Clostridium difficile</span> tratada con bezlotoxumab en un paciente trasplantado hepático" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "María Hernández, Nuria Saura, Sandra García, Raúl Velamazán, Daniel Abad, Gonzalo Hijos, Enrique Alfaro, Pablo Cañamares, Viviana Laredo, Sara Lorente" "autores" => array:10 [ 0 => array:2 [ "nombre" => "María" "apellidos" => "Hernández" ] 1 => array:2 [ "nombre" => "Nuria" "apellidos" => "Saura" ] 2 => array:2 [ "nombre" => "Sandra" "apellidos" => "García" ] 3 => array:2 [ "nombre" => "Raúl" "apellidos" => "Velamazán" ] 4 => array:2 [ "nombre" => "Daniel" "apellidos" => "Abad" ] 5 => array:2 [ "nombre" => "Gonzalo" "apellidos" => "Hijos" ] 6 => array:2 [ "nombre" => "Enrique" "apellidos" => "Alfaro" ] 7 => array:2 [ "nombre" => "Pablo" "apellidos" => "Cañamares" ] 8 => array:2 [ "nombre" => "Viviana" "apellidos" => "Laredo" ] 9 => array:2 [ "nombre" => "Sara" "apellidos" => "Lorente" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0210570520303964" "doi" => "10.1016/j.gastrohep.2020.09.015" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210570520303964?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2444382421002212?idApp=UINPBA00004N" "url" => "/24443824/0000004400000010/v1_202112030713/S2444382421002212/v1_202112030713/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific letter</span>" "titulo" => "Pericardial effusion associated with mesalamine treatment in a patient with ulcerative colitis" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "721" "paginaFinal" => "723" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Alberto Ezquerra, Elena Resina, Álvaro Montes, Tomás Álvarez-Malé, Javier P. Gisbert" "autores" => array:5 [ 0 => array:4 [ "nombre" => "Alberto" "apellidos" => "Ezquerra" "email" => array:1 [ 0 => "ezquerra93@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Elena" "apellidos" => "Resina" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "Álvaro" "apellidos" => "Montes" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 3 => array:3 [ "nombre" => "Tomás" "apellidos" => "Álvarez-Malé" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 4 => array:3 [ "nombre" => "Javier P." "apellidos" => "Gisbert" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Aparato Digestivo, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Cardiología, Hospital Universitario de La Princesa, Madrid, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Derrame pericárdico asociado al tratamiento con mesalazina en un paciente con colitis ulcerosa" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1457 "Ancho" => 2917 "Tamanyo" => 268152 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">(A) Four-chamber cine sequence showing normal-thickness pericardium with mild-moderate pericardial effusion. (B) Late enhancement sequence showing absence of enhancement in pericardial leaves, compatible with absence of active inflammation.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Mesalazine (5-aminosalicylic acid or 5-ASA) is the standard treatment for the induction and maintenance of mild/moderate flare-ups of ulcerative colitis (UC). The anti-inflammatory mechanism is not known; it is postulated that there is an increase in the expression of peroxisome proliferator-activated receptors in the intestinal mucosa and the cyclooxygenase pathway is inhibited.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Mesalazine is a safe drug that is widely used in clinical practice. Various adverse effects have been described with a low incidence and variable severity, which may lead to the drug being withdrawn. The most frequent are: arthromyalgia, abdominal pain, nausea, diarrhoea and headache. These side effects are not dose-dependent; they are due to hypersensitivity reactions and not to cumulative toxicity.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">We present the case of a 53-year-old woman, with no relevant history, diagnosed with ulcerative proctitis at another medical centre in February 2020. Treatment with oral mesalazine (500 mg/8 h) and mesalazine foam (one nocturnal application) was started at that time. She was admitted to the centre in May 2020 due to a moderate outbreak of left UC, undergoing abdominal pelvic computed tomography (CT). The CT scan showed proximal extension of the disease to the sigmoid area and a small pericardial effusion (PE). She was transferred to our hospital after a lack of response to intravenous corticosteroids for 10 days (methylprednisolone 60 mg/24 h). Cytomegalovirus infection was ruled out by rectal biopsy as the cause of corticosteroid refractoriness and treatment was started with infliximab (5 mg/kg), maintaining oral mesalazine (4 g/24 h). Given her good clinical response and test results, she was discharged from hospital. She came to the emergency department two weeks later having had fever for three days, with evening peaks of up to 38.5 °C without other associated symptoms or abdominal symptoms, and without an increase in the number of stools or bleeding. Laboratory tests showed an elevation of acute phase reactants (C-reactive protein of up to 8.9 mg/dl). An urgent abdominal CT scan was performed which identified proctosigmoiditis without local complications and worsening of the pericardial effusion. The study was completed with a transthoracic echocardiogram with a finding of a moderate effusion (17 mm) without haemodynamic compromise. The patient was admitted for study of fever without focus and PE. A rectoscopy was performed, in which a clear improvement was observed compared to the previous examination, so, given the absence of compatible symptoms, UC activity was ruled out as a cause of the fever and elevation of acute phase reactants. The PE study ruled out an infectious cause (negative PCR for respiratory viruses, including SARS-CoV-2, in nasopharyngeal exudate), as well as tumour and autoimmune causes. In the autoimmunity study, there was positivity only for p-ANCA. Cardiac magnetic resonance imaging (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>) confirmed moderate effusion and ruled out acute pericarditis or other pericardial involvement. Mesalazine was suspended as a possible causative drug and infliximab was ruled out as a cause of PE, since it was observed weeks before the drug was started. During admission, after suspension of mesalazine, the patient remained afebrile without antibiotics, antipyretics and normalisation of acute phase reactants. A follow-up echocardiogram one month after hospital discharge showed the practical resolution of PE (minimum effusion <5 mm). The patient remained afebrile after discontinuation of mesalazine two months after admission.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">Cardiac side effects related to mesalazine are reported with a frequency from 0 to 0.3%.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Among them are: cardiomyopathy, acute myocardial infarction and atrioventricular blocks.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Involvement of the pericardium, myocardium, or both (myopericarditis) is rare, but can be potentially serious and requires early detection and treatment.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> The pathophysiology of cardiac toxicity due to mesalazine is not known, and humoral (IgE-mediated) and cellular mechanisms or direct toxicity are postulated.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">In our patient, the finding of PE was incidental, since the clinical, laboratory and electrocardiogram findings were not compatible with myopericarditis. It was not accompanied by pleural effusion, positive autoimmunity (except p-ANCA, relatively common in patients with UC), or any other extraintestinal manifestation compatible with mesalazine-induced lupus. The cases of PE described in the literature are exceptional. The diagnosis is made by exclusion and from the temporal relationship with the introduction of the drug.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">In summary, mesalazine is an effective and safe drug, although cardiac side effects have been reported exceptionally. There should be a high clinical suspicion and a broad differential diagnosis should be made and, in the event of a potential causal relationship, the drug should be discontinued and not reintroduced due to the high risk of recurrence.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a></p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflicts of interest</span><p id="par0030" class="elsevierStylePara elsevierViewall">Javier Gisbert has provided scientific advice and support for research and/or training activities for MSD, Abbvie, Pfizer, Kern Pharma, Biogen, Mylan, Takeda, Janssen, Roche, Sandoz, Celgene, Gilead, Ferring, Faes Farma, Shire Pharmaceuticals, Dr Falk Pharma, Tillotts Pharma, Chiesi, Casen Fleet, Gebro Pharma, Otsuka Pharmaceutical and Vifor Pharma.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflicts of interest" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Ezquerra A, Resina E, Montes Á, Álvarez-Malé T, Gisbert JP. Derrame pericárdico asociado al tratamiento con mesalazina en un paciente con colitis ulcerosa. Gastroenterol Hepatol. 2021;44:721–723.</p>" ] ] "multimedia" => array:1 [ 0 => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1457 "Ancho" => 2917 "Tamanyo" => 268152 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">(A) Four-chamber cine sequence showing normal-thickness pericardium with mild-moderate pericardial effusion. (B) Late enhancement sequence showing absence of enhancement in pericardial leaves, compatible with absence of active inflammation.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systematic review: safety of mesalazine in ulcerative colitis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "P. Sehgal" 1 => "J.-F. Colombel" 2 => "A. Aboubakr" 3 => "N. Narula" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/apt.14688" "Revista" => array:6 [ "tituloSerie" => "Aliment Pharmacol Ther" "fecha" => "2018" "volumen" => "47" "paginaInicial" => "1597" "paginaFinal" => "1609" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29722441" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Recurrent mesalazine-induced myopericarditis in a patient with ulcerative colitis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "T. Dias" 1 => "A. Santos" 2 => "R.M. Santos" 3 => "A. Carvalho" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bcr-2018-228037" "Revista" => array:5 [ "tituloSerie" => "BMJ Case Rep" "fecha" => "2019" "volumen" => "12" "paginaInicial" => "e228037" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30709886" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mesalamine-induced myopericarditis: a case report and literature review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M.E. Taha" 1 => "A. Abdalla" 2 => "J. Al-Khafaji" 3 => "S. Malik" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.14740/cr820" "Revista" => array:6 [ "tituloSerie" => "Cardiol Res" "fecha" => "2019" "volumen" => "10" "paginaInicial" => "59" "paginaFinal" => "62" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30834061" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Massive pericardial effusion in a child following the administration of mesalamine" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "G.C. Kaiser" 1 => "D.E. Milov" 2 => "N.A. Erhart" 3 => "D.J. Bailey" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/00005176-199710000-00015" "Revista" => array:6 [ "tituloSerie" => "J Pediatr Gastroenterol Nutr" "fecha" => "1997" "volumen" => "25" "paginaInicial" => "435" "paginaFinal" => "438" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9327378" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "5-Aminosalicylic acid-associated myocarditis and pericarditis: a narrative review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "G. Brown" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Can J Hosp Pharm" "fecha" => "2016" "volumen" => "69" "paginaInicial" => "466" "paginaFinal" => "472" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28123193" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/24443824/0000004400000010/v1_202112030713/S2444382421002121/v1_202112030713/en/main.assets" "Apartado" => array:4 [ "identificador" => "77930" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Scientific letter" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/24443824/0000004400000010/v1_202112030713/S2444382421002121/v1_202112030713/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2444382421002121?idApp=UINPBA00004N" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 2 | 0 | 2 |
| 2024 October | 18 | 5 | 23 |
| 2024 September | 38 | 11 | 49 |
| 2024 August | 25 | 6 | 31 |
| 2024 July | 16 | 4 | 20 |
| 2024 June | 27 | 6 | 33 |
| 2024 May | 13 | 4 | 17 |
| 2024 April | 27 | 5 | 32 |
| 2024 March | 36 | 12 | 48 |
| 2024 February | 10 | 2 | 12 |
| 2024 January | 25 | 3 | 28 |
| 2023 December | 21 | 1 | 22 |
| 2023 September | 1 | 0 | 1 |
| 2023 April | 2 | 2 | 4 |
| 2022 October | 1 | 0 | 1 |
| 2022 March | 1 | 0 | 1 |
| 2021 December | 2 | 2 | 4 |
Show all
